Diabetes drugs may be doing more than managing blood sugar, they could also shape cancer biology in unexpected ways.

The National Pharmaceutical Pricing Authority (NPPA) has fixed the retail price of 37 new drugs in its recent meeting, under the provisions of the Drugs Prices Control Order (DPCO), 2013, including ...

Eight months after it was approved for sale in India, anti-diabetic drug Mounjaro is India’s highest-selling drug, even beating the antibiotic Augmentin, and it’s not because diabetes has spiked ...

It's like a switch that goes on and you're instantly starving,” Tanya Hall, who tried to stop taking weight loss medication ...

GLP-1 medications like semaglutide in Ozempic and Wegovy help people lose weight. But they need to be taken for years, ...

Neeraj Sharma, CEO and Managing Director of OneSource Specialty Pharma, said a recent Delhi High Court order allowing the ...

Post-diagnostic hyperglycaemia in patients with bladder cancer is associated with poor cancer-specific and overall survival, a population-based cohort study shows.

The "Liraglutide and Semaglutide - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global market for Liraglutide and Semaglutide was valued at US$17.1 ...

Weight-loss injections such as Wegovy and Ozempic are helping millions lose weight, but new reports highlight the challenges of stopping these drugs. However, according to a BBC account of a woman who ...

A collaborative study from the MRC Laboratory of Medical Sciences (LMS) and Imperial College London has found that the ...

Medications developed to control blood sugar are now at the center of a very different scientific story: how they might raise ...

Key market opportunities for liraglutide and semaglutide include their growing role in diabetes and obesity treatment due to ...